Tevogen Bio Holdings Overview
Latest ROE for Tevogen Bio Holdings: 243.15% — see history and peer comparisons.
Get informed when a big investor buys or sells
+ Follow243.15%
Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.
Tevogen Bio Holdings (TVGN) currently reports a ROE of 243.15%. That is above the sector sector average of 11.73%. Use the charts on this page to explore Tevogen Bio Holdings's ROE history and peer comparisons.
Tevogen Bio Holdings's ROE of 243.15% is higher than the its sector sector average of 11.73%. That is roughly 1972.2% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
There is no universal 'good' ROE, but Tevogen Bio Holdings's current 243.15% should be judged against industry norms (sector average: 11.73%) and against TVGN's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.
Start with the current ROE of 243.15%, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is 11.73%. From there, open related valuation or income-statement pages for Tevogen Bio Holdings, and consider following TVGN for alerts when major investors trade the stock.
